(IBTM) iBonds Dec 2032 Term - Overview
Etf: Treasury, Bonds, Fixed-Income, ETF
| Risk 5d forecast | |
|---|---|
| Volatility | 3.18% |
| Relative Tail Risk | -0.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 3.79 |
| Character TTM | |
|---|---|
| Beta | -0.054 |
| Beta Downside | -0.180 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.28% |
| CAGR/Max DD | 0.44 |
Description: IBTM iBonds Dec 2032 Term February 27, 2026
The iShares iBonds Dec 2032 Term Treasury ETF (IBTM) tracks a market-value-weighted index of U.S. Treasury securities, net of holdings by the Federal Reserve’s SOMA. The fund commits at least 80% of its assets to the index’s component securities and at least 90% to Treasuries that BFA expects will keep the ETF’s performance closely aligned with the index, except during its final liquidation phase.
As of the latest reporting, IBTM carries an expense ratio of 0.15%, holds roughly $2.1 billion in assets under management, and has an effective duration of about 8.5 years, positioning it to benefit from the current steepening of the Treasury yield curve. Recent Federal Reserve policy signals-maintaining the policy rate near 5.25%–5.50%-are supporting higher yields on medium-term Treasuries, which can enhance the fund’s total return potential.
For a deeper dive into how IBTM fits within a broader fixed-income strategy, consider exploring ValueRay’s research tools.
Altman Z''
Beneish M
| DSRI: none (Receivables none/none, Revenue 0.0/0.0) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: none (Revenue 0.0 / 0.0) |
| TATA: none (NI 0.0 - CFO 0.0) / TA none) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of IBTM shares?
Over the past week, the price has changed by +0.47%, over one month by +2.22%, over three months by +1.87% and over the past year by +6.43%.
Is IBTM a buy, sell or hold?
What are the forecasts/targets for the IBTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
IBTM Fundamental Data Overview February 26, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 528.2m USD (528.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 528.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 528.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.72% (E(528.2m)/V(528.2m) * Re(5.72%) + (debt-free company))
Discount Rate = 5.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
[DCF] Fair Price = unknown (Cash Flow 0.0)